Sponsor: 
Sanofi-Aventis Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Combination vaccines

Registered as a booster in people aged ≥10 years.

dTpa — diphtheria-tetanus-acellular pertussis combination vaccine (reduced antigen formulation)

Each 0.5 mL monodose vial contains:

  • ≥2 IU diphtheria toxoid
  • ≥20 IU tetanus toxoid
  • 2.5 µg pertussis toxoid
  • 5 µg filamentous haemagglutinin
  • 3 µg pertactin
  • 5 µg pertussis fimbriae types 2 and 3
  • 0.33 mg aluminium as aluminium phosphate
  • 0.6% v/v phenoxyethanol

Also contains traces of:

  • formaldehyde
  • glutaraldehyde

The product information and consumer medicine information for Adacel have more details.

Audience: 
Adolescents
Previous

Act-HIB

Next

Adacel Polio

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018

Definitions

dTpa
diphtheria-tetanus-acellular pertussis vaccine, reduced antigen content formulation
IU
international units